nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Editorial Board/Aims and Scope
|
|
|
2013 |
31 |
13 |
p. CO2- 1 p. |
artikel |
2 |
Enhancement of T cell-mediated immune responses to whole inactivated influenza virus by chloroquine treatment in vivo
|
Garulli, Bruno |
|
2013 |
31 |
13 |
p. 1717-1724 8 p. |
artikel |
3 |
Female human papillomavirus (HPV) vaccination: Global uptake and the impact of attitudes
|
Hopkins, Tom Glass |
|
2013 |
31 |
13 |
p. 1673-1679 7 p. |
artikel |
4 |
Hepatitis B vaccination at three months of age: A successful strategy?
|
Chiara, Federica |
|
2013 |
31 |
13 |
p. 1696-1700 5 p. |
artikel |
5 |
Immune enhancing properties of the novel Matrix-M™ adjuvant leads to potentiated immune responses to an influenza vaccine in mice
|
Magnusson, Sofia E. |
|
2013 |
31 |
13 |
p. 1725-1733 9 p. |
artikel |
6 |
Leptin-based adjuvants: An innovative approach to improve vaccine response
|
White, Sarah J. |
|
2013 |
31 |
13 |
p. 1666-1672 7 p. |
artikel |
7 |
Meta-analysis of pregnancy outcomes in pooled randomized trials on a prophylactic adjuvanted glycoprotein D subunit herpes simplex virus vaccine
|
Tavares, Fernanda |
|
2013 |
31 |
13 |
p. 1759-1764 6 p. |
artikel |
8 |
Mid-season influenza vaccine effectiveness 2011–2012: A Department of Defense Global, Laboratory-based, Influenza Surveillance System case–control study estimate
|
MacIntosh, Victor H. |
|
2013 |
31 |
13 |
p. 1651-1655 5 p. |
artikel |
9 |
Modulation of HIV peptide antigen specific cellular immune response by synthetic α- and β-defensin peptides
|
Mohan, Teena |
|
2013 |
31 |
13 |
p. 1707-1716 10 p. |
artikel |
10 |
Oral administration of an adenovirus vector encoding both an avian influenza A hemagglutinin and a TLR3 ligand induces antigen specific granzyme B and IFN-γ T cell responses in humans
|
Peters, Wendy |
|
2013 |
31 |
13 |
p. 1752-1758 7 p. |
artikel |
11 |
Outbreak-specific monovalent/bivalent vaccination to control and eradicate virulent ovine footrot
|
Dhungyel, Om |
|
2013 |
31 |
13 |
p. 1701-1706 6 p. |
artikel |
12 |
Protective immunity induced by a DNA vaccine expressing eIF4A of Toxoplasma gondii against acute toxoplasmosis in mice
|
Chen, Jia |
|
2013 |
31 |
13 |
p. 1734-1739 6 p. |
artikel |
13 |
Rabies neutralizing antibody after 2 intradermal doses on days 0 and 21 for pre-exposure prophylaxis
|
Wongsaroj, Patarapha |
|
2013 |
31 |
13 |
p. 1748-1751 4 p. |
artikel |
14 |
Review of the United States universal varicella vaccination program: Herpes zoster incidence rates, cost-effectiveness, and vaccine efficacy based primarily on the Antelope Valley Varicella Active Surveillance Project data
|
Goldman, G.S. |
|
2013 |
31 |
13 |
p. 1680-1694 15 p. |
artikel |
15 |
Systematic review of economic evaluation studies: Are vaccination programs efficient in Spain?
|
García-Altés, Anna |
|
2013 |
31 |
13 |
p. 1656-1665 10 p. |
artikel |
16 |
The impact of differential uptake of HPV vaccine by sexual risks on health inequalities: A model-based analysis
|
Malagón, Talía |
|
2013 |
31 |
13 |
p. 1740-1747 8 p. |
artikel |
17 |
Vaccination to prevent varicella
|
Myers, Martin G. |
|
2013 |
31 |
13 |
p. 1695- 1 p. |
artikel |